PRiSMA Study on Maternal and Newborn Health Monitoring Pregnancy Risks and Outcomes in Multiple Countries
Led by George Washington University · Updated on 2026-06-11
267897
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Access to quality antenatal and postnatal care is crucial to reducing pregnancy-related health problems and supporting positive birth experiences. Despite World Health Organization recommendations for eight antenatal visits, coverage and quality of care remain inconsistent, especially in vulnerable populations and resource-poor regions. This study aims to evaluate pregnancy risk factors and their links to adverse outcomes like stillbirth, neonatal mortality, and maternal morbidity in low- and middle-income countries to help improve maternal and newborn health.
The study follows a large open cohort design to gather harmonized data on maternal and newborn health from multiple centers. It observes pregnant women from early pregnancy under 20 weeks gestation through delivery and postpartum periods, focusing on risk factors and outcomes without providing specific treatments. The research collects information on maternal mortality, severe maternal outcomes, anemia, stillbirth, neonatal mortality, preterm birth, low birth weight, and small-for-gestational-age infants.
Participants will be monitored from pregnancy identification around 10-20 weeks gestation through delivery and up to one year postpartum. Assessments include maternal and infant health outcomes measured at various timepoints such as delivery, 42 days postpartum, and up to 12 months after birth. The study tracks important maternal and infant conditions, including infections, hypertension, diabetes, depression, and infant growth, aiming to better understand risks and inform future care strategies.
CONDITIONS
Brief Title
PRISMA Maternal and Newborn Health Study
Research Team
E
Emily R Smith, ScD, MPH
B
Bethany Freeman, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Meets minimum age requirement depending on country (15 years in Ghana, Pakistan, Zambia; 18 years or emancipated minor in Kenya and India)
Has an intrauterine pregnancy less than 20 weeks gestation confirmed by ultrasound
Provides informed consent
You will not qualify if you...
Has a nonviable pregnancy such as ectopic or molar pregnancy
Plans to relocate outside the study catchment area during pregnancy or postpartum
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Monitoring
Duration - Up to 1 year postpartum
Participants are observed from early pregnancy through delivery and up to one year postpartum to collect data on maternal and newborn health outcomes.
Regular visits throughout pregnancy and postpartum
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Randomized Trial Comparing Immediate Postpartum Diabetes Screening to Standard 4-12 Week Screening
and Follow-Up Study on Patient Perspectives to Improve Cardiovascular Health After Gestational Diabetes
Study of Three Times Daily Lovenox Use in Pregnant Women to Prevent Blood Clots
Effects of Commercial and Open Source Automated Insulin Delivery Systems
During Pregnancy in People with Type 1 Diabetes
Study of Continuous Glucose Monitor Use Versus Fingerstick Monitoring
in Pregnant Women With Type 2 Diabetes to Improve Pregnancy Outcomes
Comparing Oral Metformin and Injectable Insulin Treatments for Gestational Diabetes Mellitus in Pregnancy
Testing Early First Trimester Screening for Gestational Diabetes in High-Risk Pregnant Women
Study Comparing Two Antibiotic Treatments to Improve Management of Preterm Premature Rupture of Membranes in Pregnant Women
Using Ceftriaxone, Clarithromycin, and Metronidazole Versus Standard Antibiotics to Prolong Pregnancy and Improve Baby Outcomes
Comparing Intensive Versus Standard Blood Sugar Targets in Overweight and Obese Women with Gestational Diabetes A Multicenter Randomized Trial
Evaluation of Pregnancy Outcomes After Medically Assisted Fertilization in Women
With Systemic Autoimmune Rheumatologic Diseases
MOCHA Protocol Integrating Collaborative Mental Health Care for Pregnant and Postpartum Patients Hospitalized with Medical Complications
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Pregnancy Risk, Infant Surveillance, and Measurement Alliance (PRISMA) Maternal and Newborn Health Study: protocol for a multisite, prospective, open cohort study of pregnancy and postpartum health outcomes in South Asia and sub-Saharan Africa.
Pregnancy Risk, Infant Surveillance, and Measurement Alliance (PRISMA) Investigators
Protocol for the Redefining Maternal Anemia in Pregnancy and Postpartum (ReMAPP) study: A multisite, international, population-based cohort study to establish global hemoglobin thresholds for maternal anemia.